Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by SAMIR HANASH and DEBASISH TRIPATHY.
SAMIR HANASH
Connection Strength
0.466
DEBASISH TRIPATHY
  1. Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment. Breast Cancer Res. 2023 06 06; 25(1):62.
    View in: PubMed
    Score: 0.235
  2. Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment. Res Sq. 2023 Feb 14.
    View in: PubMed
    Score: 0.230
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.